Found: 26
Select item for more details and to access through your institution.
Injection-site reaction to ixekizumab histologically mimicking lupus tumidus: Report of two cases.
- Published in:
- 2018
- By:
- Publication type:
- case study
High adherence to secukinumab in patients with moderate to severe psoriasis: a long‐term multicenter study in a daily practice setting.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 3, p. e146, doi. 10.1111/ijd.16365
- By:
- Publication type:
- Article
COVID‐19 and systemic therapies in psoriasis: experience of a tertiary hospital in Madrid.
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 11, p. 1425, doi. 10.1111/ijd.15157
- By:
- Publication type:
- Article
Psoriasis and chronic myeloid leukemia: treatment with Apremilast.
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 4, p. e102, doi. 10.1111/ijd.14598
- By:
- Publication type:
- Article
Psoriatic alopecia‐like paradoxical reaction to certolizumab pegol.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Koebner phenomenon in cryoglobulinemia.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 3, p. 673, doi. 10.1007/s13555-022-00881-0
- By:
- Publication type:
- Article
Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 488, doi. 10.1002/jvc2.155
- By:
- Publication type:
- Article
Secukinumab is effective and safe in the long‐term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15929
- By:
- Publication type:
- Article
Drug survival of adalimumab biosimilars in real‐world treatment of psoriasis: A Spanish multicenter study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15831
- By:
- Publication type:
- Article
Interleukin‐23 inhibitors demonstrate high effectiveness in the treatment of a real‐world cohort of 82 psoriatic patients regardless of the HLA‐Cw6 status.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15741
- By:
- Publication type:
- Article
Two clinical subtypes with different management of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single centre experience.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 5, p. 1, doi. 10.1111/dth.15362
- By:
- Publication type:
- Article
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52‐week results from MATURE, a randomized, placebo‐controlled trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 3, p. 1, doi. 10.1111/dth.15285
- By:
- Publication type:
- Article
Successful treatment of resistant pityriasis rubra pilaris with ixekizumab.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 4, p. 1, doi. 10.1111/dth.13644
- By:
- Publication type:
- Article
NanoString analysis of mycosis fungoides reveals individual molecular identity.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 6, p. 812, doi. 10.1093/bjd/ljad061
- By:
- Publication type:
- Article
Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the BIOBADADERM registry.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 5, p. 817, doi. 10.1111/bjd.21763
- By:
- Publication type:
- Article
Palmoplantare Pustulose unter Secukinumab bei zwei Patienten ohne Psoriasis.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2022, v. 20, n. 1, p. 106, doi. 10.1111/ddg.14639_g
- By:
- Publication type:
- Article
Palmoplantar pustulosis under secukinumab in two patients without psoriasis.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2022, v. 20, n. 1, p. 106, doi. 10.1111/ddg.14639
- By:
- Publication type:
- Article
Behçet‐ähnliche Erkrankung unter Secukinumab‐Behandlung: neue paradoxe Reaktion?
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2021, v. 19, n. 1, p. 116, doi. 10.1111/ddg.14196_g
- By:
- Publication type:
- Article
Behçet's‐like disease during secukinumab treatment: new paradoxical reaction?
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2021, v. 19, n. 1, p. 116, doi. 10.1111/ddg.14196
- By:
- Publication type:
- Article
Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.
- Published in:
- International Wound Journal, 2017, v. 14, n. 6, p. 1382, doi. 10.1111/iwj.12746
- By:
- Publication type:
- Article
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 3, p. 355, doi. 10.1093/bjd/ljad382
- By:
- Publication type:
- Article
Eczematous reactions induced by anti-IL17 agents: Report of two cases and possible pathogenic mechanisms.
- Published in:
- Indian Journal of Dermatology, 2022, v. 67, n. 3, p. 307, doi. 10.4103/ijd.IJD_448_20
- By:
- Publication type:
- Article
Apremilast as a new treatment option for Acrodermatitis continua of Hallopeau.
- Published in:
- Australasian Journal of Dermatology, 2019, v. 60, n. 3, p. e237, doi. 10.1111/ajd.12990
- By:
- Publication type:
- Article
Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate‐to‐severe plaque psoriasis patients in conditions close to clinical practice.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. 2004, doi. 10.1111/jdv.19229
- By:
- Publication type:
- Article
Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 1004, doi. 10.1111/jdv.18846
- By:
- Publication type:
- Article